Anti-inflammatory Nutrition on the Outcomes of Non-surgical Periodontal Therapy

ConditionPeriodontitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age20-65
SponsorRecep Tayyip Erdogan University Training and Research Hospital

About this trial

This study aimed to determine the effect of anti-inflammatory nutrition on non-surgical periodontal treatment in individuals with periodontitis by evaluating gingival crevicular fluid (GCF) and serum biomarkers and clinical periodontal parameters.

A total of 100 volunteers identified as having a pro-inflammatory diet (Q3 and Q4) will be included in the study. Individuals will be assigned to two groups. These groups will then be further divided into two groups based on whether or not they will receive anti-inflammatory nutrition education. Group Q3-1 (n=25) will receive non-surgical periodontal treatment and anti-inflammatory nutrition education. Group Q3-2 (n=25) will receive only non-surgical periodontal treatment. Group Q4-1 (n=25) will receive non-surgical periodontal treatment and anti-inflammatory nutrition education. Group Q4-2 (n=25) will receive only non-surgical periodontal treatment. After the periodontal index measurements are completed, the patients will receive non-surgical periodontal treatment. GCF and serum samples, periodontal clinical parameters and Dietary Inflammatory Index will be collected 3 times: at baseline, 1.5 and 3 months after non-surgical periodontal treatment. Levels of interleukin (IL)-1β, IL-10, tumor necrosis factor (TNF)-α, total oxidant status (TOS), total antioxidant status (TAS), and C-reactive protein (CRP) will be assessed from these samples. This will investigate the role of anti-inflammatory nutrition in reducing periodontal inflammation and increasing treatment success.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Being systemically healthy

Not smoking

Not using anti-inflammatory drugs in the last 3 months, antibiotics, or systemic corticosteroids in the last 6 months

Not being pregnant or lactating

Disqualifiers

Having a systemic disease

Smoking

Using anti-inflammatory drugs within the last 3 months, antibiotics within the last 6 months, or systemic corticosteroids

Being pregnant or lactating

Trial population

This study included individuals who applied to Recep Tayyip Erdogan University, Faculty of Dentistry, Department of Periodontology for treatment

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • non surgical periodontal trearment

    Other intervention

    All participants will receive nonsurgical periodontal treatment

  • anti-inflammatory nutrition education

    Other intervention

    Participants in Groups Q3-1 and Q4-1 will receive anti-inflammatory nutrition education

Treatment groups

100 Participants
are divided into 4 treatment groups
Group A: Q3-1: Nonsurgical periodontal treatment and anti-inflammatory nutrition education2 interventions
Group B: Q3-2: Only nonsurgical periodontal treatment1 intervention
Group C: Q4-1: Nonsurgical periodontal treatment and anti-inflammatory nutrition education2 interventions
Group D: Q4-2: Only nonsurgical periodontal treatment1 intervention

Trial outcomes

Primary outcomes

1

periodontal pocket depth

It will be calculated by measuring the distance between the gingival margin and the pocket base. It will be measured from the six surfaces of each tooth and the average will be taken higher scores indicate worse outcome.

Time frame
baseline, after nonsurgical periodontal treatment at 1.5 months, after nonsurgical periodontal treatment at 3 months.
2

Clinical attachment loss

It will be calculated by measuring the distance between the cementoenemal border and the pocket base. It will be measured from the six surfaces of each tooth and the average will be taken higher scores indicate worse outcome.

Time frame
baseline, after nonsurgical periodontal treatment at 1.5 months, after nonsurgical periodontal treatment at 3 months.

Secondary outcomes

1

interleukin (IL)-1β level

IL-1β levels will be measured with biochemical kits.

Time frame
baseline, after nonsurgical periodontal treatment at 1.5 months, after nonsurgical periodontal treatment at 3 months.
2

interleukin (IL)-10 level

IL-10 levels will be measured with biochemical kits.

Time frame
baseline, after nonsurgical periodontal treatment at 1.5 months, after nonsurgical periodontal treatment at 3 months.
3

tumor necrosis factor (TNF)-α level

TNF-α levels will be measured with biochemical kits.

Time frame
baseline, after nonsurgical periodontal treatment at 1.5 months, after nonsurgical periodontal treatment at 3 months.
4

serum total oxidant status (TOS) level

TOS levels in serum will be measured with biochemical kits.

Time frame
baseline, after nonsurgical periodontal treatment at 1.5 months, after nonsurgical periodontal treatment at 3 months.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.